In this report, we explore the nature of the inductive stimuli leading to expression of the divergently regulated lymphokines interleukin 2 (IL-2) and interleukin 4 (IL-4). Elevation of cAMP levels blocks IL-2 induction while sparing IL-4 induction. These effects are gene-specific, not cell-specific, and can be observed in the same cells. Transient transfection experiments using murine IL-2 regulatory sequences to drive expression ofa reporter gene show at least part of the inhibition to act at the transcriptional level. The possible biological significance of these results is indicated by the observation that representative type 2 helper T-cell lines maintain significantly higher levels of cAMP per cell than a type 1 helper T-cell line. Fresh splenic CD4+ T cells, which preferentially make IL-2, have particularly low levels of cAMP per cell and a low capacity to elevate cAMP in response to forskolin.
However, their response to forskolin increases significantly after several days of stimulation. These results suggest a potential link between differential cAMP regulation and the divergence of memory T cells into effector subsets.
Subsets of T cells may be defined by the way they utilize similar stimuli to effect distinct outcomes at the transcriptional level. For example, activated type 1 helper T-cell (TH1) lines synthesize interleukin 2 (IL-2), interferon-y, and lymphotoxin in preference to IL-4 and IL-5, which are the products of type 2 helper T (TH2) cells (1) . Both TH subsets use CD4 as a coreceptor and recognize antigen in association with class II major histocompatibility complex molecules. A central question is at what level the mechanisms operate that restrict T cells to one or another response type. The induction of either type of gene expression response depends on two steps: (i) the coupling of membrane receptors to intracellular signaling pathways and (ii) the effect of the resulting signaling mediators on transcription factors and/or on chromatin structure and RNA stability. It is known that the frequency of IL-2 producers in various populations and the levels of IL-2 mRNA that they accumulate are a function of the particular activating stimulus used (2) (3) (4) . This suggests that the ultimate response phenotype of a T cell may not be heritably fixed but may be influenced by the type of external stimulus it receives.
In fact, several recent reports suggest that upon repeated exposure to antigen, CD4+ T cells in vivo do shift their response type. In certain cases, the population appears progressively to lose the ability to express IL-2 while enhancing its ability to make IL-4 (5-7). An important question is whether such T-cell populations are developmentally preprogrammed to differentiate from IL-2 producers to IL-4 producers or whether instead they may be altered by the particular signaling events induced by contact with antigen. Signaling modulation could either result in preferential activation of a preexisting T-cell subset or result in "instructive" modification of the gene batteries expressed by individual responding cells. The phenomenon of THI-specific induction of anergy (8) (9) (10) (11) is an example of the former mechanism. Differences between THi and TH2 clones in the coupling of their T-cell receptors (TCR) to signaling cascades (12) reinforce this concept of preexisting distinctions. On the other hand, the tendency of rare clones producing both IL-2 and IL-4 to lose expression of IL-2 preferentially, either on extended passage (13) or on acute exposure to glucocorticoids (14) , is an example of the latter.
This report demonstrates that the common second messenger cAMP may participate in shifts to TH2-like responses in individual cells. Established TH2 cells were found to maintain significantly higher levels of intracellular cAMP than THi cells. When stimuli that bypass the TCR are used to induce both IL-2 and IL-4 in model systems, the presence of cAMP agonists selectively blocks IL-2 induction without affecting the induction of IL-4. The blockade of IL-2 synthesis appears to be exerted at least partly by gene-specific inhibition of transcription from the IL-2 promoter. Most strikingly, the differential effects of cAMP on IL-2 and IL-4 expression need not simply reflect differences among cellular subsets in susceptibility to inhibition, because they can be observed in the same cells.
MATERIALS AND METHODS
Drugs and Reagents. Stocks of the phorbol ester phorbol 12-myristate 13-acetate (PMA) and the calcium ionophore A23187 were made up in Me2SO and used at final concentrations of 10 ng/ml for PMA and 37 ng/ml for A23187. The adenylate cyclase activator, forskolin, N6,02'-dibutyryladenosine 3',5'-cyclic monophosphate (Bt2cAMP), and prostaglandin E1 (PGE1) were purchased from Sigma and Calbiochem. In all cases the final organic solvent concentration was 0.1%.
Cell Lines. The TH1 line A.E7 and the TH2 lines D10.G4.1 and CDC-25 were passaged every 7-10 days with antigen and mitomycin C-treated feeder cells as described (15) (16) (17) . The murine thymoma EL4.E1, the human T-leukemic line Jurkat, and the IL-3-dependent premast cell line 32Dcl5 were grown as described (18 Immunology: Novak and Rothenberg have been described in detail elsewhere (18) . Transfection of exponentially growing cells and assay of CAT activity were as described in detail (18) . RNA Extraction and Analysis. Cytoplasmic RNA was extracted by the method of Favaloro et al. (19) and analyzed as described (18) .
cAMP Assay. Cells were resuspended at 1.5 x 106 cells per ml in complete medium containing various stimuli. After incubation for 15 min at 370C, the reactions were terminated in liquid N2. Ethanol was added to 65% and the tubes were vortex mixed until the cell pellet thawed. After clarification, supernatants were transferred to fresh tubes, dried in a vacuum centrifuge, and stored at -20'C until assayed. Assays were performed on extracts from 2 x 104 to 1.5 x 105 cell equivalents using a dual-range radioimmunoassay kit (Amersham). All samples and standards were acetylated according to the manufacturer's instructions prior to being assayed. In the absence of competition, 60-65% of the total tracer was precipitated and 2 fmol of competitor could readily be detected.
RESULTS
TCR signaling induces IL-2 expression by the inositol phospholipid pathway, using elevated intracellular Ca2+ and protein kinase C activation as dominant mediators (20) . Agonists that raise levels of intracellular cAMP can sharply antagonize IL-2 induction (21-23). One proposed mechanism for the inhibitory effect of cAMP is that it acts to uncouple the TCR from the pathway generating inositol phospholipid breakdown products (24, 25) . Here we show that it can also block IL-2 induction when saturating Ca2+ and protein kinase C signals are provided. Fig. 1 shows that even in the presence of optimal concentrations of PMA and A23187, which bypass the requirement for TCR coupling to phospholipase C, IL-2 RNA induction can be blocked in both EL4.E1 (Fig. 1A) and Jurkat ( (26) (27) (28) . Thus, the sensitivity to inhibition by elevated cAMP levels seems to be characteristic of the IL-2 induction pathway per se and not a peculiarity of signal generation in a given cell type. IL-4 expression can also be induced in response to A23187 and PMA, and two cell lines programmed to express IL-4 are analyzed in Fig. 2 . The cAMP insensitivity of IL-4 RNA induction was demonstrable not only in the D10.G4.1 and 32Dcl5 cells but also in EL4.E1 cells themselves. These tumor cells, unlike most long-term T-cell lines, express both IL-2 and IL-4 upon induction (Fig. 1A, lane 2) . In the presence of cAMP agonists, even in the absence of any detectable IL-2 RNA, the IL-4 RNA levels induced in these cells (relative to actin RNA) were unchanged (Fig. 1A, lanes 3, 4, 5, and 7) . Thus, even within the same cells, expression of IL-2 and IL-4 RNA appears to be regulated by distinct gene-specific pathways, only one of which is inhibited by cAMP.
IL-2 RNA accumulation is controlled both at the level of transcriptional induction and at the level ofRNA stabilization (32, 33) . To assess whether cAMP inhibits at the transcriptional level, we utilized a series of chimeric DNA constructs that we have derived (18) in which various extents of murine IL-2 regulatory sequence drive expression of a bacterial CAT gene. In these constructs, the sequences that target natural IL-2 RNA for degradation are deleted, and the level of CAT enzyme produced predominantly reflects promoter activity. Fig. 3 shows the effects of cAMP elevation on levels of CAT activity expressed in EL4.E1 and Jurkat cells transiently transfected with these constructs, with pRSV-CAT as a control. In all cases, the cells were stimulated after transfection, as described (18) , and the figure shows the activity of each construct after stimulation in the presence of the indicated drugs as a fraction of its activity after stimulation in the which is also up-regulated by PMA and A23187, was minimally inhibited in Jurkat cells and actually increased an additional 4-fold in EL4.E1 cells under these conditions. Thus, the suppressive effects of cAMP on the pIL-2-CAT plasmids are not attributable to a generalized downregulation of transcription, translation, or activation pathways. Instead, the same intracellular signal in the same T-cell population gives different effects on transcriptional induction, depending on the inducible gene being studied. Thus, at least one component of the cAMP effect on IL-2 induction affects transcriptional activity of the IL-2 gene in a promoterspecific manner.
Although cAMP agonists only partially inhibited IL-2-CAT expression, the inhibition was most pronounced at early times after induction. The greater inhibitory effect seen at 18 hr in the experiment shown with Jurkat (>75% inhibition) as compared to EL4.E1 (50%o) reflected the slower kinetics of IL-2-CAT induction in Jurkat cells (unpublished observations). When extracts of stimulated EL4.E1 cells were assayed at 5 hr rather than 18 hr, 10 AtM forskolin also caused more severe inhibition (.70%; also, P. M. White and E.V.R., unpublished results). The initial kinetics of CAT product accumulation are more likely to be dominated by relative transcription rates per se and less by effects on transcript stability and translational efficiency than later plateau values. The greater inhibition at early times thus supports the interpretation that cAMP in fact inhibits transcription from the IL-2 promoter.
Other mechanisms might contribute to the effect of cAMP on IL-2 accumulation. The degree of inhibition of IL-2-CAT expression by cAMP was consistently less severe than the inhibition of endogenous IL-2 RNA accumulation. However, as the kinetics of IL-2-CAT induction in EL4.E1 cells are slower than those of IL-2 mRNA induction, single time-point measurements of their accumulated levels may not be directly comparable. Our results could suggest either that the effect of cAMP is transient or that it exerts some effects on IL-2 RNA at the post-transcriptional level.
To assess the biological significance of increased intracellular cAMP, we examined several T-cell populations that selectively produce IL-2 or IL-4. In addition to the TH2 lines D10.G4.1 and CDC-25, we also examined a cloned THi line, A.E7 (16) . When assayed 7 days after stimulation with antigen, D10 cells contained 3 times more cAMP on a per-cell basis than A.E7 cells (Table 1) . This difference in baseline cAMP levels was also seen 4 days after antigenic stimulation when both lines were actively proliferating. Another TH2 line, CDC-25, contained even higher levels of cAMP. Thus, A.E7 cells maintain a low level of cAMP that is independent of their proliferative status.
The level of cAMP in these lines did not change significantly after stimulation with PMA plus A23187 or anti-CD3 plus IL-1. It therefore appears that the stable response phenotypes of these cloned lines are correlated with stably maintained differences between their levels of cAMP. Because cell lines may not be representative of normal cells, we also examined cAMP levels in CD4+ splenic T cells. This laboratory has shown (3) that almost 100% of these cells synthesize IL-2 mRNA in response to PMA plus A23187. These cells have also been shown to secrete little, if any, IL-4 (5, 34). As shown in Table 1 , freshly isolated CD4+ T cells have resting levels of cAMP that are comparable to or slightly lower than those of A.E7 cells. Intriguingly, they even manifest a poor response to forskolin at this time. After several days of culture in the presence of concanavalin A and IL-4, many CD4+ T cells acquire the ability to secrete IL-4 (35) . These cells still maintained a relatively low level of cAMP that did not change when stimulated with PMA plus A23187 or anti-CD3 plus IL-1. However, they had acquired the ability to respond well to forskolin, a property that was evident by day 2 of culture. It is therefore possible that these cells could increase their intracellular pools of cAMP significantly more than fresh CD4+ cells if they were triggered appropriately (see below). Thus, while the details of any such developmental changes remain to be explored, the results presented in Table 1 support a correlation between high cAMP levels and preferential production of IL-4 relative to IL-2. CD3/IL-1 173 D10.G4.1, CDC-25, and A.E7 cells were stimulated with antigenand mitomycin C-treated spleen cells on day 0. Four and 7 days later cells were harvested and assayed for cAMP after no treatment (-) or after 15 min at 370C with the indicated stimuli. In experiment 1, healthy CDC-25 cells were assayed 24 hr after thawing. Spleen cells were depleted of B cells by "panning" on goat anti-mouse immunoglobulin-coated plates and CD8' T cells were eliminated by two rounds of complement-mediated lysis (day 0). Day 2 spleen cells were grown in the presence of concanavalin A (3 ,ug/ml) and PMA (3 ng/ml). Day 4 cells received concanavalin A (2 ,ug/ml) on day 0. On day 1 the cells received 5% (vol/vol) EL4-conditioned medium and recombinant IL-4 (20 units/ml). Cells were stimulated with PMA and A23187 at concentrations of 10 ng/ml and 37 ng/ml, respectively. Anti-CD3 (E) antibody 145-2C11 was used to coat polystyrene tubes and recombinant human IL-la was used at a final concentration of 100 units/ml. Forskolin was used at 10 ,uM. *Day 0 cells were >95% CD4+ T cells in experiment 1 (38) (39) (40) (41) . B-cell help commonly reflects the production of IL-4 and IL-5 more than that of IL-2 (42). Furthermore, CD29, or a close relative, appears to act as a Peyer's patch homing receptor (43) [i.e., a component of the mechanism that selectively concentrates those helper cells in vivo whose effects are most TH2-like]. It is thus particularly interesting that CD29 molecules can directly transduce signals leading to sustained cAMP accumulation, with concomitant decreases in the inducibility of IL-2 (37) . The memory-cell marker may thus participate in directing the memory-cell-specific response.
Proc. Nati. Acad. Sci. USA 87 (1990) Of course, the ability of cAMP agonists to mimic the "6THO" to "TH2" transition in one step does not prove that cAMP is the primary regulator of T-cell functional type. It does, however, suggest a general theme for the programming of T-cell effector subclasses. Use of common second messengers like cAMP in a critical balance with other activation signals to dictate not only the magnitude but also the nature of a response provides a highly plastic, reversible way of controlling functional identity. It may be that such mechanisms play a dominant role in the differentiation of the highly diverse family of hematopoietic cell types.
Note. After this manuscript was submitted, Mufioz et al. (44) reported results complementary to ours and confirmed that forskolin and cholera toxin block PMA plus ionomycin induction of IL-2 in a TH1 line.
